PNC Financial Services Group
IRLA

PNC Financial Services Group’s IRulya Therapeutics Inc. Common Stock IRLA Stock Holding History

PNC Financial Services Group’s Portfolio IRLA Stock Details IRLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Hold
0
– -$50 – 4816
2023
Q1 		– Hold
0
– – – 4641
2022
Q4 		– Hold
0
– – – 4744
2022
Q3 		– Hold
0
– – – 4580
2022
Q2 		– Hold
0
– – – 4673
2022
Q1 		– Sell
-1
Closed -$1.36K – 4671
2021
Q4 		$2K Buy
+1
New +$6.1K ﹤0.01% 4183

Other funds holding IRLA

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
ECG
EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KAM
Knightsbridge Asset Management Newport Beach, California $762M AUM 59.13% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Alphabet Inc
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PNC Financial Services Group's IRLA Position: Q2 2023 in Review

PNC Financial Services Group held its IRulya Therapeutics Inc. Common Stock (IRLA) position steady in Q2 2023 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #4816.

PNC Financial Services Group first reported a position in IRLA in Q4 2021 and has held it in 1 quarter since. The position peaked at $2K in Q4 2021. 38 funds tracked by Wall St. Rank hold IRLA as of Q2 2023.

  • PNC Financial Services Group held 0 shares of IRulya Therapeutics Inc. Common Stock worth $0 as of Q2 2023.
  • PNC Financial Services Group left its IRulya Therapeutics Inc. Common Stock share count unchanged in Q2 2023.
  • IRulya Therapeutics Inc. Common Stock made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2023, its #4816 holding.
  • PNC Financial Services Group first reported a position in IRulya Therapeutics Inc. Common Stock in Q4 2021 and has held it in 1 quarter since.
  • PNC Financial Services Group's IRulya Therapeutics Inc. Common Stock position peaked at $2K in Q4 2021.
  • 38 funds tracked by Wall St. Rank held IRulya Therapeutics Inc. Common Stock as of Q2 2023.

Based on PNC Financial Services Group's 13F filing for Q2 2023, filed 11 Aug 2023.